Overview
Properties
Constituents: 0.1% BSA, PBS, pH 7.2
Concentration information loading...Applications
Our Abpromise guarantee covers the use of ab41706 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| WB | |
| Blocking |
WB: Use at an assay dependent dilution. Predicted molecular weight: 244 kDa.
The peptide is used for blocking the antibody activity of DATF1. It usually blocks the antibody activity completely in Western blot analysis by incubating the peptide with equal volume of antibody for 30 minutes at 37degC.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Protein info
-
Alternative names
- BYE 1BYE1C20orf158
- DATF 1DATF-1Death associated transcription factor 1Death inducer obliterator 1Death-associated transcription factor 1Death-inducer obliterator 1DIDO 1DIDO 2DIDO 3DIDO1DIDO1_HUMANDIDO2DIDO3DIO 1DIO-1DIO1dJ885L7.8DKFZp434P1115FLJ11265hDido 1hDido1KIAA0333MGC16140
see all
Contains 1 TFIIS central domain.
Target information above from: UniProt accession
Q9BTC0
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
References for DATF1 peptide (ab41706)
ab41706 has not yet been referenced specifically in any publications.